Rajeev Rangachari Plans to Bolster a Culture of Innovation
Waltham, MA, October 23, 2023 — Trinity Life Sciences, a leader in global life sciences commercialization solutions, today announced the appointment of Rajeev Rangachari to serve as the Company’s first-ever Chief Technology Officer (CTO). Mr. Rangachari brings significant experience in building flexible, scalable solutions for life sciences organizations to Trinity.
As CTO, Mr. Rangachari will infuse technology into every aspect of Trinity’s offerings and workflow, accelerating business processes with technology assets.…
Read Now
New White Paper Maps Out Method that Significantly Improves Prediction of Future Prescribing Behavior in Demand Studies
Waltham, MA, October 11, 2023 — Trinity Life Sciences, a leader in global life sciences commercialization solutions, introduces the first method that incorporates Healthcare Professionals (HCP)-specific real-world behaviors to improve share calibration for forecasting. The method, called “tethering,” uses real-world prescribing behaviors to calibrate share estimates from primary market research (PMR) by connecting them to the current market scenario. This real-world calibration at…
Read Now
Waltham, MA, October 9, 2023 – Trinity Life Sciences, a leader in global life sciences commercialization solutions, has made available its TGaS Advisors’ white paper “The Globalization Marathon: Is Pharma Commercial Operations Moving to a Full Global Operating Model?” The white paper is based on primary research conducted by TGaS with a subset of its ~100 member companies’ Commercial Operations leaders representing large, mid-size and emerging pharmaceutical companies operating in global markets.
The research found that most organizations are not…
Read Now
New White Paper Analyzes Launches Since the Start of the COVID Pandemic to Profile Key Strategies that Improve Commercialization Success
Waltham, MA, October 2, 2023 — Trinity Life Sciences, a leader in global life sciences commercialization solutions, announces the availability of Trinity Launch Accelerator 2.0 to provide smart, efficient launch planning with customized, tech-enabled support. Built and powered by Trinity’s Launch Center of Excellence (COE), Launch Accelerator 2.0 is an easy-to-use cloud-based project management tool that leverages recent “real world”…
Read Now
Waltham, MA, September 20, 2023 — Trinity Life Sciences, a leader in global life sciences commercialization solutions, has announced its Board of Advisors, a group of independent, expert advisors that will help advance Trinity’s mission.
The Board of Advisors includes:
Susan DenmanMs. Denman is formerly with Johnson & Johnson where she held senior management roles including WW Vice President of Transfusion Medicine, WW VP of Innovation for Ortho Clinical Diagnostics, WW VP for the $2.4B Johnson’s Baby business, WW VP of…
Read Now
Waltham, MA, August 23, 2023 — Trinity Life Sciences, a leader in global life sciences commercialization solutions, was identified as a Sample Vendor in four sections within the July 2023 Gartner Hype Cycle for Life Sciences Commercial Operations report. The sections where Trinity was named are:
AI (Artificial Intelligence) in Commercial Operations
Advanced Decision Support for Sales
Personalization Engines in LS (Life Science)
D&A (Data & Analytics) Platforms in Commercial LS
As Gartner explains: “Life science organizations strive to balance…
Read Now
Waltham, MA, August 15, 2023 — Inc. revealed today that Trinity Life Sciences, a leader in global life sciences commercialization solutions, was named to the Inc. 5000 list for the third year in a row. The prestigious ranking provides a data-driven look at the most successful companies within the economy’s most dynamic segment – its independent, entrepreneurial businesses.
“We are thrilled to again be named to the Inc. 5000 list of fastest growing private companies in America,” said Leslie Orne,…
Read Now
Trinity Annual Drug Index Now Available
Waltham, MA, July 18, 2023 — Trinity Life Sciences, a leader in global life sciences commercialization solutions, announced the availability of its Trinity Annual Drug Index, an evaluation of the actual commercial performances over 3 years of 53 novel drugs approved in 2019.
This year’s report, the fifth in Trinity’s Drug Index series, outlines key themes and emerging trends as the life sciences industry moves towards a new world of targeted and innovative products. Scoring…
Read Now
Upcoming Demo Maps Out an Enterprise-Wide Approach to Delivering Meaningful Competitive Insights that Shape Strategy
Waltham, MA, July 13, 2023 — Trinity Life Sciences, a leader in global life sciences commercialization solutions, announces the launch of the Market Intelligence Dashboard to meet the needs of Competitive Intelligence (CI) teams and their end users. Built and powered by Trinity’s Dynamic Market Intelligence Center of Excellence (COE), the Market Intelligence Dashboard provides a steady stream of curated data and insights through the…
Read Now
David Fitzhenry to Remain a Strategic Advisor and Board Member
Waltham, MA, June 7, 2023 — Trinity Life Sciences, a leader in global life sciences commercialization solutions, announced today the appointment of Leslie Orne as Chief Executive Officer (CEO) effective July 1. Ms. Orne, who is currently the President and Chief Commercial Officer at Trinity, succeeds David Fitzhenry, who has held various leadership roles at Trinity for 26 years. Mr. Fitzhenry will remain active with the Company as a strategic advisor…
Read Now
